文献速递妇科

子宫内膜癌微创手术中前哨淋巴结定位的应用与结局

Uptake and outcomes of sentinel lymph node mapping in women undergoing minimally invasive surgery for endometrial cancer.
PubMed 文献 · BJOG · 2022-01-25

基于美国2012至2018年Perspective数据库的回顾性队列研究,纳入45381例子宫内膜癌微创子宫切除术患者,分析前哨淋巴结(SLN)定位的应用趋势与结局。SLN定位比例从1.8%升至35.3%,淋巴结清扫从63.5%降至39.1%(p<0.001)。SLN定位并发症率5.9%,低于淋巴结清扫的7.3%(aRR 0.85,95%CI 0.77-0.95)。

要点

  • SLN定位使用率从2012年1.8%升至2018年35.3%,淋巴结清扫从63.5%降至39.1%。
  • SLN定位并发症率5.9%,低于淋巴结清扫的7.3%(aRR 0.85,95%CI 0.77-0.95)。
  • SLN定位中位住院费用10479美元,淋巴结清扫10747美元,均高于无淋巴结评估的9149美元(p<0.001)。

核心结论

  • 子宫内膜癌SLN定位实施率上升,与淋巴结清扫相比与更低的并发症率相关,但较单纯子宫切除术显著增加费用。

研究设计与样本

  • 回顾性队列研究,使用2012至2018年Perspective数据库,纳入45381例子宫内膜癌行腹腔镜或机器人辅助子宫切除术的女性。

主要发现

  • 7768例(17.1%)行SLN定位,23214例(51.2%)行淋巴结清扫,14399例(31.7%)未行淋巴结评估。
  • SLN定位从2012年1.8%升至2018年35.3%,淋巴结清扫从63.5%降至39.1%(p<0.001)。
  • 在行淋巴结评估的女性中,居住于西部、白人种族及机器人辅助子宫切除术与SLN定位相关(p<0.05)。
  • SLN定位并发症率5.9%,淋巴结清扫为7.3%(aRR 0.85,95%CI 0.77-0.95)。
  • SLN定位中位住院费用10479美元,淋巴结清扫10747美元,均高于无淋巴结评估的9149美元(p<0.001)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To examine the patterns and outcomes of sentinel lymph node (SLN) assessment in women with endometrial cancer. DESIGN: Retrospective cohort study. SETTING: United States inpatient and outpatient hospital services. POPULATION: Women with endometrial cancer who underwent a laparoscopic or robotic-assisted hysterectomy. METHODS: The Perspective Database from 2012 to 2018 was used. Performance of lymph node dissection was classified as SLN mapping, lymph node dissection or no nodal evaluation. Adjusted regression models were developed to examine the association between SLN mapping and morbidity and cost. MAIN OUTCOME MEASURES: Utilisation rates, morbidity and cost of both lymph node dissection and SLN mapping. RESULTS: Among 45 381 patients, SLN mapping was performed for 7768 patients (17.1%), lymph node dissection was performed for 23 214 patients (51.2%) and no lymphatic evaluation was performed for 14 399 patients (31.7%). SLN mapping increased from 1.8% in 2012 to 35.3% in 2018, whereas the rate of lymph node dissection decreased from 63.5% to 39.1% (p < 0.001). Among women who underwent nodal evaluation, residence in the west, White race and use of robotic-assisted hysterectomy were associated with SLN mapping (p < 0.05 for all). The complication rate was 5.9% for SLN mapping, compared with 7.3% in those that underwent lymph node dissection (aRR 0.85, 95% CI 0.77-0.95). The median hospital costs for women who underwent SLN mapping ($10 479) and lymph node dissection ($10 747) were higher than for those who did not undergo nodal assessment ($9149) (p < 0.001). CONCLUSIONS: The performance of SLN mapping is increasing for endometrial cancer. Compared with lymph node dissection, SLN mapping is associated with lower morbidity. SLN mapping significantly increases the costs compared with hysterectomy alone. TWEETABLE ABSTRACT: SLN mapping is increasing rapidly for endometrial cancer and is associated with decreased perioperative morbidity.

来源:BJOG,查看原文。版权归原作者所有。

引用

  1. Dioun S, Chen L, Melamed A, et al. Uptake and outcomes of sentinel lymph node mapping in women undergoing minimally invasive surgery for endometrial cancer. BJOG. 2022. PMID: 34962708. doi:10.1111/1471-0528.17085

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。